Development of new indicators for the launch of AMED (6) : A disease-specific overview and future prospects of pharmaceutical industry

DOI Web Site Web Site 4 Citations 5 References
  • OSABE Yoshiyuki
    The Organisation for Economic Co-operation and Development (OECD) Japan Patent Office
  • JIBU Mari
    The Organisation for Economic Co-operation and Development (OECD) Japan Science and Technology Agency (JST) Institute for Technology, Enterprise and Competitiveness, Doshisha University

Bibliographic Information

Other Title
  • AMED（日本版NIH）創設に向けた新しい指標の開発（6）　疾病別にみた医薬品開発の現状俯瞰・将来予測
  • AMED(ニホンバン NIH)ソウセツ ニ ムケタ アタラシイ シヒョウ ノ カイハツ(6)シッペイ ベツ ニ ミタ イヤクヒン カイハツ ノ ゲンジョウ フカン ・ ショウライ ヨソク

Search this article

Abstract

For the sake of providing evidences that contribute to policy making or strategy planning in AMED (a Japanese version of the NIH) and pharmaceutical companies, we tried to give an overview and future prospects of pharmaceutical industry based on new indicators. Here we show the trends of drug R&D by type of disease, focusing on the indication that each R&D pipeline has. In particular, we analyze drug R&D by International Patent Classifications (IPC) and individual diseases.

Journal

Citations (4)*help

See more

References(5)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top